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Acute effects of fine particulate matter
(PM2.5) on hospital admissions for
cardiovascular disease in Beijing, China: a
time-series study
Endawoke Amsalu1,2†, Tianqi Wang1,3†, Haibin Li1,2†, Yue Liu1,2, Anxin Wang1,2, Xiangtong Liu1,2, Lixin Tao1,2,
Yanxia Luo1,2, Feng Zhang1,2, Xinghua Yang1,2, Xia Li4, Wei Wang5 and Xiuhua Guo1,2*
Abstract
Background: Air pollution and cardiovascular disease are increasing problems in China. However, the short-term
association between fine particulate matter (PM2.5) and cardiovascular disease (CVD) is not well documented. The
purpose of this study is to estimate the short-term effects of PM2.5 on CVD admissions in Beijing, China.
Methods: In total, 460,938 electronic hospitalization summary reports for CVD between 2013 and 2017 were obtained.
A generalized additive model using a quasi-Poisson distribution was used to investigate the association between
exposure to PM2.5 and hospitalizations for total and cause-specific CVD, including coronary heart disease (CHD), atrial
fibrillation (AF), and heart failure (HF) after controlling for the season, the day of the week, public holidays, and weather
conditions. A stratified analysis was also conducted for age (18–64 and≥ 65 years), sex and season.
Results: For every 10 μg/m3 increase in the PM2.5 concentration from the previous day to the current (lag 0–1) there
was a significant increase in total CVD admissions (0.30, 95% CI: 0.20, 0.39%), with a strong association for older adults
(aged ≥65 years), CHD (0.34, 95% CI: 0.22 to 0.45%) and AF (0.29, 95% CI, 0.03 to 0.55%). However, the observed
increased risk was not statistically significant for HF hospitalizations. The associations in the single-pollutant models
were robust to the inclusion of other pollutants in a two-pollutant model. No differences were found after stratification
by sex and season.
Conclusions: Exposure to PM2.5 increased the risk of hospitalizations from CVD, especially for CHD, and appeared to
have more influence in the elderly. Precautions and protective measures and efforts to reduce exposure to PM2.5
should be strengthened, especially for the elderly.
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Introduction
Despite considerable progress in the reduction of air pol-
lution and its corresponding impact on health, air pollu-
tion studies have attracted more attention [1]. PM2.5 is the
most sensitive marker of air pollution and environmental
risk factors [2]. The effect of PM2.5 on CVD risk has been
widely reported by both short- and long-term epidemio-
logical studies [3, 4]. However, there is limited evidence
from countries where severe environmental pollution and
cardiovascular morbidity and mortality have become a
challenge, particularly in Asian developing countries [5].
In China, 27% of cities experience extreme air pollution,
and morbidity and mortality from CVD have been rising
[6]. Several studies associate an increase in CVD morbid-
ity and mortality with PM2.5 air pollution [7–9]. However,
most of these studies mainly focus on emergency room
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visits and cause-specific CVD mortality [10–12]. For in-
stance, a multicity study in China showed that a 10 μg/m3
increase of PM2.5 was associated with an increase in daily
cardiovascular disease mortality of 0.315% (95% CI:
0.133–0.497%) [13]. Although the use of hospital admis-
sions is a more sensitive indicator than mortality [14] and
has great public health importance, adverse short-term ef-
fects of PM2.5 on cause-specific CVD hospital admissions
are not well documented in large cities such as Beijing.
Moreover, the impact of PM2.5 on the city-specific level
has not been comprehensively reported. In this study, we
estimate the daily effect of PM2.5 on admissions for CVD
and its subtypes (coronary heart disease: CHD, heart
failure: HF, and atrial fibrillation: AF) in Beijing using a
single-pollutant model, a two-pollutant model, and several
subgroup analyses.
Methods
Cardiovascular data
Records from hospital admissions for CVD between 1 Janu-
ary 2013 and 31 December 2017 were extracted from the
Beijing Public Health Information Center (http://www.phic.
org.cn/). We extracted information on the patient’s date of
hospital admission, principal diagnosis, age, and sex from
each hospital admission record. Cause-specific CVD hospi-
talizations were identified based on the International Classi-
fication of Diseases, 10th Revision (ICD-10) codes: CHD
(ICD-10: I20-I25), AF (ICD-10: I48) and HF (ICD-10: I50).
In this study, the total number of CVD admissions was cal-
culated as the sum the number of CHD, AF and HF admis-
sions. Hospital admissions for CVD for patients under 18
years old were excluded from the current analysis because
of the small number of records.
We did not use individual data identifiers; therefore,
informed consent was not specifically required, but an
official permit was required to access the data. The Insti-
tutional Review Board of Capital Medical University ap-
proved the study protocol (IRB00009511).
Air pollution and meteorological data
Air pollution data were obtained from 35 fixed-site air
quality–monitoring stations from Beijing Municipal Envir-
onmental Protection Bureau (http://www.bjepb.gov.cn/)
between 1 January and 31 December 2017, covering nearly
every district (at the county level) in Beijing. The 24-h
average concentrations of five pollutants were used in this
study: particulate matter with an aerodynamic diameter
less than 2.5 μm (PM2.5), carbon monoxide (CO), sulfur
dioxide (SO2), nitrogen dioxide (NO2) and the daily max-
imum 8-h average ozone concentrations (O3). In addition,
the mean air pressure, the daily mean temperature and
the mean relative humidity were extracted for the same
study period from the China Meteorological Data Sharing
Service System (https://data.cma.cn/en).
Study design
An ecological time series design was conducted to esti-
mate the association between the short-term effects of
PM2.5 and hospital admissions for CVD. A time-series
analysis based on general additive models have been
widely used in epidemiological studies of air pollution to
explore the short-term effects of air pollutant exposure
on the risk of acute events.
Statistical analysis
A generalized additive model using a quasi-Poisson distribu-
tion was applied to estimate the effect of PM2.5 on hospital
admissions for CVD. The core model adjusted for the sea-
son, public holidays, the day of the week (DOW), and a
long-term trend was created. A spline S (.) with 7 degrees of
freedom (df) per year for a given time period was used to
control for seasons and long-term trends, and 3 degrees of
freedom (df) were used for temperature and relative humid-
ity. DOW was used as a categorical variable, and public holi-
days were included as a two-level factor. The degrees of
freedom (df) for calendar time, temperature and relative hu-
midity were selected based on the parameters used in previ-
ous studies and were further tested by sensitivity analyses. A
nonlinearity test using smoothing splines and 3 df graphically
described the relationship (lag 0–1). A delayed-effect associ-
ation was analyzed with separate lag structures for single day
lags (from lag 0 to lag 3) and multiday lags (lag 0–1 and lag
0–3). We calculated the percentage change from the relative
risk and Z-value to test the statistical significance of each
subgroup difference with the formula Z ¼ ðβ1−β2Þ=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE21 þ SE22
q
, where β1 and β2 are the effect estimates for
the two categories, and SE1 and SE1 are their respective cor-
responding standard errors [10]. We used a two-step model.
First, the model that included the main single pollutant
(PM2.5) was entered alone. Second, two-pollutant models for
SO2, CO, O3, and NO2 were created, and the effects were es-
timated. Subgroup analyses by sex, age, and seasonal vari-
ation were also performed. We mainly reported the effect of
PM2.5 using a 2-day moving average concentration (lag 0–1)
because this lag was more strongly associated with health ef-
fects. Additionally, to avoid the likely bias of the estimate of
the effect PM2.5 due to an inadequate control of temporal
trends, we also performed an analysis by period to evaluate
possible temporal trends in the health effects. Therefore, we
conducted an analysis for each year and reported the per-
centage change with 95% confidence intervals for a 10 μg/m3
increase in PM2.5. All data analyses were conducted with R
version 3.0.1 (R Development Core Team, 2013).
Sensitivity analysis
We conducted a series of sensitivity analyses by using
alternative degrees of freedom (df) for calendar time,
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temperature and humidity. We used 5–10 df per year
for time and 3–10 df for temperature and humidity [15].
Results
In total, 460,938 hospital admissions from CVD were re-
ported during the 5-year study period in Beijing, includ-
ing 378,090 CHD, 24,455 AF and 58,393 HF admissions.
Of these admissions, 54.9% were men, and 37.6% were
under 65 years of age (Additional file 1). Table 1 shows
the statistical descriptions of the daily hospital admis-
sions for CVD, air pollution concentrations, and weather
conditions. There were 252 hospital admissions from
CVD per day on average.
During the study period, the mean daily pollution con-
centration was 76.9 μg/m3 for PM2.5, 15.3 μg/m
3 for SO2,
and 49.7 μg/m3 for NO2, and the mean 8-h maximum con-
centration for O3 was 95.7 μg/m
3. The daily mean ambient
temperature was 13.9 °C, the relative humidity was 24.4%,
and the air pressure was 1016.7 hPa (Table 1).
To visualize seasonal and long-term trends, we plotted
the CVD admissions, atmospheric pollutants and meteoro-
logical factors against time using time-series graphs (Fig. 1).
Table 2 shows Spearman’s correlations for different air
pollution concentrations and weather conditions during
the study period. There were strong-to-moderate positive
correlations between PM2.5 and CO (r = 0.724), NO2 (r =
0.722) and PM10 (r = 0.841), but the correlation between
PM2.5 and O3 was negative and weak (r = − 0.1127).
Fig. 2 shows the exposure-response relationship curve
of the PM2.5 concentrations with total and cause-specific
CVD admissions at lag0–1. The estimated dose-response
relationships of the PM2.5 concentrations with total
CVD and CHD admissions showed a linear relationship
with a sharp increase in the dose-response function at
lower concentrations (0–50 μg/m3) and a moderate
increase at higher concentrations. For HF, the curve
tended to plateau at higher PM2.5 concentrations
(200 μg/m3). For AF, there appeared to be a small in-
crease in the risk until the PM2.5 concentration exceeded
approximately 190 μg/m3.
Fig. 3 shows the effect of PM2.5 (per 10 μg/m
3 increase)
with 95% CIs for daily hospital admissions for CVD, CHD,
HF and AF for single and cumulative lag days. We found
evidence for significant positive associations for at least
one exposure lag structure between day-to-day variations
in the PM2.5 concentration and hospital admissions for all
cardiovascular outcomes, except for HF. The largest effect
was observed at lag 3 for the single-day effect and at
lag 0–3 for the cumulative day effect for total CVD,
CHD and AF. A 10 μg/m3 increase from the previous
day to the current day (lag0–1) in the single-pollutant
model was associated with significant increases in hos-
pital admissions for CVD (0.30, 95% CI: 0.20, 0.39%),
CHD (0.34, 95% CI: 0.22, 0.45%), and AF (0.29, 95% CI:
0.03, 0.55%). No significant association was observed
for HF (all P > 0.05).
Table 1 Statistical descriptions of cardiovascular admissions, atmospheric pollutants, and meteorological variables during the study
period (2013–2017)
Minimum P25 Median Mean (SD) P75 Maximum
Hospital admission
Cardiovascular disease 9 106 192 252.4 (165.1) 405 749
Coronary heart disease 2 77 159 207.1 (141.8) 340 632
Atrial fibrillation 0 4 10 13.4 (10.5) 22 53
Heart failure 0 20 29 32.0 (15.5) 43 90
Atmospheric pollutants
SO2 (μg/m3) 0 4 8 15.31 (18.31) 19 133
NO2 (μg/m3) 0 34 44. 49.69 (23.34) 61 155
O3 (μg/m3) 0 49 81 95.66 (63.039) 136 367
PM10 (μg/m3) 0 50 86 102.30 (75.88) 130 820
PM2.5 (μg/m3) 0 30 59 76.86 (66.38) 102 477
Meteorological factors
Average Temperature (°C) −16.92 0.99 14.52 13.09 (12.34) 24.09 38.51
Maximum Temperature (°C) −13.41 11.88 24.60 24.62 (15.80) 35.83 59.89
Minimum Temperature (°C) −19.16 −3.88 6.98 6.16 (12.08) 17.06 30.94
Humidity (%) 1.121 5.24 7.47 24.38 (26.66) 43.30 95.30
Air pressure (hPa) 970.5 985.50 993.0 993.90 (10.51) 1001.5 1022.40
P25 = 25th percentile. P75 = 75th percentile. CO = carbon monoxide. PM2.5 = particulate matter with an aerodynamic diameter less than 2.5 μm. SO2 = sulfur dioxide.
NO2 = nitrogen dioxide. O3 = ozone
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Fig. 1 Time series plot of atmospheric pollutants and total CVD admissions from 2013 to 2017
Table 2 Spearman’s correlations between each atmospheric pollutants and meteorological factors in Beijing, 2013-2017b
Variables SO2 CO NO2 O3 PM10 PM2.5 Temp Humidity
SO2 1.000
CO 0.6039 1.0000
NO2 0.6552 0.7221 1.0000
O3 −0.3621 − 0.4185 −0.4062 1.0000
PM10 0.5715 0.5783 0.7005 −0.0304 1.0000
PM2.5 0.5607 0.7246 0.7170 −0.1127 0.8417 1.0000
Temp −0.4938 − 0.3407 − 0.3014 0.8102 − 0.0197 − 0.0588 1.0000
Humidity −0.3893 0.0429 −0.0118 0.0108 −0.0279 0.0779 0.1052 1.0000
b All correlation coefficients were statistically significant (P < 0.001)
Temp: Temperature
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Table 3 shows the two-pollutant model for the effects
of PM2.5 at the current and previous lag day (lag 0–1)
effect. The observed associations in the single-pollutant
models were robust to the inclusion of the copollutants
in the two-pollutant model. For CVD, the observed as-
sociations in the single pollutant model were robust but
were attenuated with the inclusion of all copollutants
except for O3 (0.31, 95% CI: 0.22, 0.40%). For CHD, the
observed associations in the single-pollutant model
were robust to the inclusion of copollutants and the
association with NO2 was slightly increased (0.95, 95%
CI: 0.75, 1.15%). For AF, the effect of PM2.5 was elimi-
nated after adjusting for other copollutants, except for
O3. However, the model remained trivial for HF after
controlling for all pollutants (Table 3).
Table 4 presents the analysis for the period. For the
whole period 2013–2017, we found evidence of signifi-
cant positive associations at lag 0–1 between day-to-
day variations in the PM2.5 concentration and hospital
admissions for all cardiovascular outcomes. When
models were analyzed for periods, the effect estimate
for hospital admission become weaker and sharply de-
creased. A10 μg/m3 increase in PM2.5 exposure at lag
0–1 was associated with percent increase in hospital
admissions for the total CVD (0.30, 95% CI; 0.20,0.39%)
in 2013, (0.45, 95% CI; 0.30,0.60%) in 2014, (0.23, 95%
CI;0.08,0.38%) in 2015, (− 0.30, 95%CI, − 0.69, 0.08%) in
2016 and (− 0.61, 95% CI, − 1.43, 0.22%) in 2017. A
similar decline in effect estimate for cause-specific car-
diovascular disease was also observed (Table 4).
Fig. 4 shows the associations between the PM2.5 con-
centrations and hospital admissions for CVD, CHD, AF
and HF stratified by age group (lag 0–1 days). We ob-
served a significant difference between age groups at a
moving average of lag0–1, with an interaction P = 0.001,
for total CVD. No significant difference was observed
after stratifying by sex and season.
The effect estimate of PM2.5 on CVD hospital admis-
sions was relatively insensitive to the number of df speci-
fied for calendar time, for smoothing of temperature and
Fig. 2 Exposure-response relationship curves for the association between hospital admissions for total and cause-specific cardiovascular disease
and the 2-day moving average (lag 0–1) of PM2.5 concentrations
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Fig. 3 Percentage changes with 95% confidence intervals of hospital admissions for total and cause-specific cardiovascular disease associated
with a 10 μg/m3 increase in daily PM2.5 concentrations with varying lag patterns
Table 3 Percentage changes with 95% confidence intervals for the increase in daily cardiovascular admissions with a 2-day moving
average (lag 0–1) based on particulate matter (PM2.5) concentrations with and without adjustment for copollutants in Beijing, 2013–
2017
Pollutants CVD AF CHD HF
Unadjusted PM2.5 0.30 (0.2,0.39) 0.29 (0.03,0.55) 0.34 (0.22,0.45) 0.10 (− 0.07,0.26)
Adjusted for SO2 0.23 (0.11,0.36) 0.12 (−0.21,0.45) 0.27 (0.13,0.42) 0.09 (− 0.12,0.3)
Adjusted for CO 0.26 (0.12–0.40) 0.28 (−0.19–0.75) 0.30 (0.14,0.46) 0.14 (− 0.24,0.52)
Adjusted for NO2 0.29 (0.16,0.42) 0.26 (−0.17,0.7) 0.95 (0.75,1.15) 0.13 (−0.18,0.39)
Adjusted for O3 0.31 (0.22,0.40) 0.31 (0.05,0.57) 0.35 (0.24,0.46) 0.11 (−0.05,0.27)
Data are percentage changes (%) and 95% confidence intervals
CO = carbon monoxide. PM2.5 = particulate matter with an aerodynamic diameter less than 2.5 μm. SO2 = sulfur dioxide. NO2 = nitrogen dioxide. O3 = ozone
CVD: Cardiovascular disease. CHD: Coronary Heart Disease
HF: Heart Failure. AF: Atrial Fibrillation
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Table 4 Percent change per 10 μg/m3 increase in PM2.5 for each year for cardiovascular hospital admission in Beijing, China
Year Cardiovascular Disease Coronary Heart Disease Heart Failure Atrial Fibrillation
2013
Lag0 0.22(0.09,0.35) 0.23(0.09,0.37) 0.26(− 0.04,0.56) − 0.24(− 0.7,0.23)
Lag1 0.19(0.11,0.27) 0.20(0.11,0.29) 0.34(0.2,0.66) − 0.16(− 0.91,0.61)
Lag2 0.19(0.12,0.26) 0.21(0.13,0.28) −0.01(− 0.34,0.32) 0.23(− 0.27,0.74)
Lag3 0.21(0.14,0.28) 0.22(0.15,0.29) 0.01(−0.35,0.37) 0.59(0.11,1.07)
Lag01 0.30(0.20,0.39) 0.12(−0.06,0.29) 0.43(− 0.05,0.80) − 0.31(− 1.14,0.52)
Lag02 0.39(0.29,0.49) 0.10(− 0.12,0.32) 0.44(− 0.03,0.91) − 0.17(− 1.17,0.84)
Lag03 0.54(0.42,0.67) 0.34(0.06,0.61) 0.52(− 0.06,1.10) 0.36(− 0.83,1.57)
2014
Lag0 0.34(0.22,0.46) 0.38(0.25,0.50) 0.12(−0.18,0.41) 0.50(0.09,0.92)
Lag1 0.30(0.17,0.43) 0.33(0.19,0.47) 0.08(−0.21,0.38) 0.42(−0.03,0.88)
Lag2 0.27(0.14,0.40) 0.09(−0.14,0.22) 0.15(−0.17,0.48) 0.30(− 0.16,0.75)
Lag3 0.09(−0.30,0.21) 0.09(− 0.14,0.22) 0.15(− 0.17,0.48) 0.11(− 0.52,0.74)
Lag01 0.45(0.30,0.60) 0.50(0.34,0.66) 0.14(−0.2,0.48) 0.66(0.15,1.18)
Lag02 0.68(0.49,0.86) 0.76(0.55,0.96) 0.26(−0.17,0.70) 0.9(0.25,1.56)
Lag03 0.84(0.60,1.07) 0.93(0.68,1.18) 0.36(−0.17,0.90) 1.26(0.45,2.07)
2015
Lag0 0.11(−0.02,0.24) 0.11(−0.03,0.26) 0.11(− 0.15,0.37) 0.29(− 0.09,0.67)
Lag1 0.23(0.10,0.36 0.23(0.09,0.37) 0.18(−0.1,0.46) 0.39(−0.02,0.80)
Lag2 0.10(−0.04,0.24) 0.11(−0.06,0.28) − 0.03(− 0.31,0.26) 0(−0.51,0.50)
Lag3 0.14(0.02,0.27) 0.14(0.01,0.27) 0.08(−0.29,0.45) 0.31(−0.08,0.70)
Lag01 0.23(0.08,0.38) 0.24(0.07,0.40) 0.19(−0.13,0.51) 0.47(0,0.95)
Lag02 0.29(0.11,0.47) 0.30(0.01,0.50) 0.17(−0.22,0.56) 0.46(−0.12,1.03)
Lag03 0.40(0.19,0.61) 0.42(0.09,0.64) 0.18(−0.28,0.64) 0.76(−0.06,1.58)
2016
Lag0 0.07(00.3, 0.17) −0.12(− 0.40,0.13) 0.27(− 0.14,0.69) −0.21(−1.50,1.09)
Lag1 −0.45(− 0.81,-0.09) −0.52(− 1.00,-0.13) −0.19(− 0.86,0.48) −1.44(−2.35,-0.53)
Lag2 −0.35(− 0.7,-0.01) −0.56(− 1.00,-0.13) −0.03(− 0.47,0.54) −0.24(− 1.21,0.74)
Lag3 − 0.05(− 0.30,0.20) −0.035(− 0.30,0.23) 0.08(− 0.45,0.61) −0.25(− 1.15,0.66)
Lag01 − 0.3(− 0.69,0.08) −0.38(− 0.79,0.03) 0.09(− 0.5,0.68) −1.44(− 2.56,-0.32)
Lag02 −0.54(− 1.04,-0.03) −0.72(− 1.25,-0.20) 0.12(− 0.65,0.89) −1.74(− 2.99,-0.69)
Lag03 −0.67(− 1.31,-0.03) −0.90(− 1.56,-0.23) 0.17(− 0.65,1.00) − 2.36(−4.01,-0.69)
2017
Lag0 − 0.66(− 1.04,-0.27) −0.56(− 1.01,-0.11) −0.58(− 1.26,0.10) −0.79(− 2.94,1.39)
Lag1 − 0.0013(− 0.75,0.50) −0.53(− 1.05,-0.01) −0.13(− 0.75,0.50) −0.14(− 1.72,1.48)
Lag2 − 0.025(− 1.15,1.10) −0.16(− 2.09,1.77) −0.04(− 0.15,0.07) −1.08(− 1.35,-0.81)
Lag3 −0.96(− 1.39,1.54) −0.06(− 1.73,1.60) −0.09(− 0.39,0.21) −1.42(− 1.69,-0.57)
Lag01 −0.66(− 1.43,0.10) −0.84(− 1.46,-0.21) −0.61(− 1.43,0.22) −1.01(− 3.39,1.37)
Lag02 − 0.28(− 1.21,0.66) −0.01(− 0.94,0.92) −0.13(− 1.21,0.66) −0.10(− 2.72,2.52)
Lag03 − 0.51(− 0.52,1.63) −0.015(− 0.12,2.18) −0.51(− 0.59,0.63) −3.34(− 0.22,-6.46)
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Fig. 4 Percentage changes in daily hospital admissions for total and cause-specific cardiovascular disease for each 10 μg/m3 increase in the 2-day
moving average (lag0–1) concentration of PM2.5, stratified by sex (male and female), season (cold and warm) and age (< 65 and≥ 65 years)
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for relative humidity (see Additional file 1: Table S1),
suggesting that our core model is relatively robust to
model specification.
Discussion
In the present study, a time-series analysis based on a
generative additive Poisson model was used to investi-
gate the associations between PM2.5 and hospitaliza-
tions for CVD in Beijing from 2013 to 2017. Short-
term exposure to PM2.5 was found to be significantly
associated with an increased risk of hospital admis-
sions for CVD, CHD and AF, but not for HF. Robust
findings were found after controlling for other pollut-
ants in the two-pollutant models.
Previously, studies have shown positive associations
between PM2.5 and CVD morbidity and mortality [7, 8,
13]. For example, a study conducted by Xu et al. found
that a 10 μg/m3 increase in the PM2.5 concentration was
associated with a 0.56% increase in CHD admissions at
lag0–1 (95% CI: 0.16–0.95%), a 0.81% increase in heart
rhythm disturbances (HRD) at lag0–1 (95% CI: 0.05–
1.57%) and a 1.21% increase heart failure (HF) emer-
gency room visits on the same day (95% CI: 0.27–2.15%)
[16]. Chen C et al. conducted a multicounty time-series
study demonstrated that a 10 μg/m3 increase in PM2.5
was associated with a 0.12% increase in cardiovascular
disease (CVD) (95% CI, 0.001–0.25), a 0.42% increase in
myocardial fraction (95% CI, 0.03–0.81), and a 0.17% in-
crease in coronary heart disease (95% CI, − 0.04-0.40)
[17]. A case-crossover study conducted with 12,865 pa-
tients in Utah, USA found that a 10 μg/m3 increase in
PM2.5 concentration was associated with a 4.5% increase
in the risk of acute ischemic coronary events (95% CI,
1.1 to 8.0%) [18]. A study conducted in Madrid, Spain,
reported that a 10 μg/m3 increase in PM2.5 concentration
on the same day was significantly associated with an
11.08%: (95% CI: 1.03, 1.13%) increase for hospital ad-
missions due to circulatory causes [19]. Moreover, in dif-
ferent studies, the impact of PM2.5 on CVD is robust
when adjusting for copollutants [16]. For example, a
study conducted by Qu et al. found that the estimated
effects of PM2.5 were robust after adjusting for SO2, O3,
CO and NO2 [11]. Similarly, the association between
PM2.5 concentration and ischemic stroke at lag 0 to 1
days was maintained after adjusting for other air pollut-
ants (NO2, photochemical oxidants, or SO2) [20]. Our
current findings were consistent with those of previous
studies that explored the association between PM2.5
exposure and the risk of hospital admission for CVD
after adjusting for CO, NO2, SO2 and O3.
China, the largest developing country, has the highest
ambient PM2.5 levels worldwide because of rapid
urbanization and its energy consumption is the highest
[1, 21]. The high level of urban PM2.5 in Chinese
megacities (such as Beijing, Shanghai, Chongqing and
Guangzhou) mainly originates from sources such as traf-
fic-related emissions, road/soil dust, biomass burning,
and agriculture activities as well as regional transported
aerosols [22, 23], but research remains limited and the
adverse health effects of PM2.5 on cardiovascular hos-
pital admissions need to be quantified. Our findings
were supported by a recent study conducted in Beijing,
China that reported a 10 μg/m3 increase in PM2.5 con-
centrations on the same-day PM2.5 concentrations was
associated with a 0.31% increase in the daily admissions
for ischemic stroke (95% CI, 0.17–0.45%) [24]. A 10 μg/
m3 increase in PM2.5 was associated with a 0.27% in-
crease in CHD morbidity (95% CI 0.21 to 0.33%). More-
over, a per 10 μg/m3 increase in PM2.5 at lag 3 was
associated with a 0.14% increase in cardiovascular visits
(95% CI: 0.01–0.27%) [11]. Our results were consistent
with previous studies performed in different Chinese cit-
ies that reported a significant PM2.5 exposure effect on
lag 0 day and lag 1 day and a maximum PM2.5 exposure
effect on lag 3 days.
Estimates of short term effect using time series studies
are not confounded by factors that vary slowly over time.
Based on various time series review, Bell Ml et al. con-
cluded that the effect estimates for particulate matter
and mortality are unlikely to be biased to a large degree
by inadequate control for temporal trend [25]. However,
proper adjustment for temporal trend is still a concern
in today. In this study, we conducted an analysis by year
for the effect estimate of PM2.5 to evaluate some possible
temporal trends in hospitalization for CVD. We found a
trend of decline in short-term effect of PM2.5 on
hospitalization for CVD from 2013 to 2017. Our study
provides the association between daily changes in PM2.5
levels and hospitalization is decreased sharply over time.
A declining trend in the short-term risk estimates is evi-
dence that the day-to-day association between PM2.5
and hospitalization from total and cause-specific CVD is
getting weaker over time, possibly as a result of changes
in the composition and toxicity of the PM2.5 from the
air quality control programs [26, 27]. Moreover, a time
trend of declining effect may be possibly as a result of
greater exposure measurement error at lower levels of
PM2.5; flattening of the exposure-response relation at
lower concentrations of PM2.5; and a change in the
underlying susceptibility of the population, a decline in
smoking or reducing CVD rates [28, 29].
The exposure-response relationship assessment is cru-
cial for public health policy as is the need for decision-
making regarding the air pollution limit for PM2.5. A
linear relationship was observed between PM2.5 levels
and mortality due to diseases of the circulatory system
in Madrid, Spain [30]. Nevertheless, the exposure-re-
sponse relationship in severe air pollution environments
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such as Beijing remains unclear. In this study, we con-
ducted an exposure-response relationship analysis to ex-
plore the pattern and scope of the adverse response. We
observed an approximately linear exposure-response rela-
tionship, which is consistent with the recent study that ex-
plored the exposure-response relationship pattern for
respiratory emergency visits related to PM2.5 [16]. Simi-
larly, our study was supported by a study of 63,956 first
hospital admissions for ischemic stroke, suggesting that
the relationship was approximately linear, with a small
fluctuation at lower concentrations (< 100 μg/m3) and a
sharper increase at higher concentrations [24]. Moreover,
a study involving 369,469 ischemic heart disease cases in
Beijing suggested that PM2.5 at levels below 75 μg/m
3 do
not significantly increase the risk of ischemic heart dis-
ease, which is consistent with our study [31]. Based on
these findings, we hypothesized that there might be a
threshold concentration at which PM2.5 becomes harmful
enough to impose an adverse impact on the development
and progression of cardiovascular disease. Future studies
are needed to clarify this important issue.
In this study, we also found that the association be-
tween short-term PM2.5 exposure and hospital admission
varied by cause-specific CVD. The adverse effect was ob-
vious and robust for daily hospitalizations for CHD and
AF but not for HF. Adverse effects due to a short-term
exposure to PM2.5 for CHD, AF and HF was also evident
in other studies [18, 31, 32]. However, some inconsistent
results have been reported for PM2.5 exposure for HF
[33–36]. For example, Poloniecki et al. in London,
United Kingdom, and Symons et al. in Baltimore, Mary-
land, USA, found no statistically significant associations
between any pollutant and hospital admissions for HF
[35, 36]. One explanation may be that HF is clinically
heterogeneous and complicated by a large number of co-
morbid diseases that may result in outcome misclassifi-
cation [37]. Similarly, misclassification of cardiovascular
events was detected among the study participants in Bal-
timore, Maryland [36]. Furthermore, a study by Dabass
et al. in the National Health and Nutrition Examination
Survey (NHANES) confirmed no significant associations
for either short-or long-term PM2.5 exposure with HF
risk in the general adult population, but stronger associ-
ations were found among clinically heterogeneous and
comorbid disease participants [38].
Increased vulnerability to PM2.5 health effects might
be more common among more exposed populations
[39]. Thus, consideration of the effect of PM2.5 on differ-
ent these groups is crucial for public health policy. Some
studies reported an increased risk of cardiovascular ad-
missions in women and elderly people [31, 33, 34, 39].
In the present study, a difference in effect was found
among elderly people (age ≥ 65) with a 0.52% increased
risk (P = 0.001) for CVD hospitalization, but this effect
was not present after stratifying by sex and season.
Overall, our study found a more consistent and in-
creased effect for CHD compared with AF and HF,
which is supported by the 2010 evidence summary re-
port from the American Heart Association (AHA) [39].
The short-term association of PM2.5 with CVD
hospitalization is consistent with previous epidemio-
logical studies, although the mechanisms of the PM2.5
effect remain unclear. However, different potential
mechanisms have been proposed, such as oxidative
stress, inflammation, elevation in stress hormones and
metabolic alterations [39, 40]. After inhalation of PM2.5,
a local inflammatory response is developed, and several
proinflammatory mediators, such as IL-6 and TNF-α,
are also increased, which induces an increase in the con-
centrations of blood fibrinogen and C-reactive protein
(CRP), which are important markers of cardiovascular
events. Numerous studies have demonstrated that ex-
posure to particulate matter is associated with increased
fibrinogen and CRP, resulting in an increased risk of
CVD [41–43]. PM2.5 exposure can also disturb the auto-
nomic nervous system (ANS) and results in heart rate
variability (HRV), which is another potential mechanism
for CVD [44]. Recent research demonstrates that PM2.5
also directly affects the cardiovascular system by enter-
ing into the systemic circulation and causing myocardial
dysfunction through mechanisms of reactive oxygen spe-
cies production, calcium ion interference, endothelial
cell damage and vascular dysfunction [42, 45, 46].
This study has several strengths. First, cardiovascular
hospital admissions data were obtained from an estab-
lished monitoring system covering more than 172 com-
prehensive hospitals in Beijing, which resulted in a
relatively large sample size. Second, compared with pre-
vious studies, a relatively larger sample size and recent
data over a 5-year period were used, which allowed us to
examine the associations at high levels of validity and re-
liability. Third, the inclusion of all 35 monitoring sites
for air pollution better represents the effects of air pollu-
tion than other studies. However, this study also has lim-
itations. Similar to other studies involving explorations
of the impact of air pollutants on health outcomes, we
need to carefully interpret and infer the causal relation-
ship between PM2.5 exposure and hospitalizations for
CVD due to the ecological design of the present study.
Future epidemiological cohort studies are needed for the
assessment of cause-specific cardiovascular disease,
especially in elderly people.
Conclusions
This study shows that short-term exposure to ambient
PM2.5 significantly increased the risk of hospitalizations
from total CVD, especially for CHD. Our results also
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provided evidence of the risk of air pollution due to PM2.5,
which was relatively higher among older people. Precau-
tions and protective measures and efforts to reduce expos-
ure to PM2.5 should be strengthened, especially for elderly
people.
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